EUVIMED · CrossrefJournal
Journal of Clinical Lipidology
ISSN 1933-2874 · Elsevier BV
Latest articles
Signal vs noise when examining discordance between LDL-cholesterol and apolipoprotein-B
Interpreting TyG performance in adolescent prediabetes: Does the diagnostic definition matter?
Clinical and biochemical profile of c.703G>T p.(Glu235*): A novel pathogenic CYP27A1 variant of Cerebrotendinous Xanthomatosis
Dyslipidemia in Thin, Young, and “Triple-Negative” South Asians: Insights and a Wake Up Call from the ICMR-INDIAB
Ocular manifestations of lipid disorders: Clinical clues for lipidologists narrative review
Long-term lipoprotein (a) category stability and transitions in patients with cardiovascular disease
Oral PCSK9 Inhibition in the Injectable Era: Repositioning Intensive LDL-Cholesterol Lowering in Contemporary Cardiovascular Prevention
Reply to the Letter to the Editor: “Interpreting TyG Performance in Adolescent Prediabetes: Does the Diagnostic Definition Matter?”
Dyslipidemia as a Risk Factor for Pregnancy Loss: A Systematic Review
Lipoprotein(a) as a Biomarker in the Acute Myocardial Infarction Setting
Paediatric Sitosterolemia With Two Novel ABCG8 Variants of Uncertain Significance in Trans
Diet quality, PCSK9 inhibitor use, and plasma lipids among adults with heterozygous familial hypercholesterolemia: a cross-sectional study.
Pharmacokinetic evidence of an abiraterone–rosuvastatin drug interaction resulting in rhabdomyolysis and acute kidney injury
Translating the familial hypercholesterolemia pediatric diagnostic score (FH-PeDS) into clinical practice: Development of an open-access online tool
Novel mutation in sitosterolemia: A rare cause of hyperlipidemia
Potential for cardiovascular benefits of resmetirom based on LDL-cholesterol and lipoprotein(a) lowering consistent across statin subgroups, a secondary analysis of the MAESTRO-NASH phase 3 clinical trial
Lipoprotein-insulin resistance score is associated with atherosclerotic cardiovascular disease in liver transplant recipients
GPIHBP1 autoantibody positivity in patients with recurrent severe hypertriglyceridemia: Frequency, phenotype, and derivation of an exploratory screening score
Extreme HDL-C elevation associated with homozygous CETP deficiency and a SCARB1 variant: A case illustrating the HDL paradox
A new lipoprotein lipase gene mutation discovered in a family with hypertriglyceridemia
The effect of evinacumab on the clinical outcomes of dyslipidemia: A systematic review of randomized controlled trials
Trends in dyslipidemia among youth from the US and Korea: Based on the NHANES and KNHANES 2007-2023
Phenotype-informed lipid management across the care continuum of hypertriglyceridemia-associated acute pancreatitis: A narrative review
Uncovering Racial Disparities in Lipoprotein(a) Testing Utilization: A Systematic Review and Meta-analysis
Revisiting the paradoxical effects of artichoke leaf extract in severe obesity
Long-term knowledge and screening outcomes following a gamified lipoprotein(a) curriculum for internal medicine residents at a large academic ambulatory practice
HDL function after PCSK9 inhibition: Assay scope, normalization, and clinical interpretation
Bempedoic acid vs ezetimibe in routine care: Observation time, residual confounding, and endpoint interpretation
PREVENT-ASCVD in the 2026 Dyslipidemia Guidelines
Efficacy and safety of inclisiran monotherapy in Chinese adults with elevated low-density lipoprotein cholesterol: Results from the VICTORION-Mono China trial
EUVIMED